Open AccessEfficacy of Combination Antibiotic Therapy for Refractory Pediatric Inflammatory Bowel Disease
Author(s) -
Jessica Breton,
Arthur Kastl,
Natalie V. Hoffmann,
Rachel Rogers,
Andrew B. Grossman,
Petar Mamula,
Judith R. Kelsen,
Robert N. Baldassano,
Lindsey Albenberg
Publication year - 2019
Publication title -
inflammatory bowel diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.932
H-Index - 146
eISSN - 1536-4844
pISSN - 1078-0998
DOI - 10.1093/ibd/izz006
Subject(s) - medicine , inflammatory bowel disease , refractory (planetary science) , antibiotics , inflammatory bowel diseases , antibiotic therapy , intensive care medicine , gastroenterology , disease , microbiology and biotechnology , physics , astrobiology , biology
Recent studies have shown that oral combination antibiotics may improve disease course in refractory inflammatory bowel disease (IBD). Here, we describe the use of combination oral antibiotics as salvage therapy in refractory ulcerative colitis (UC), Crohn's colitis, and IBD-unclassified (IBD-U) at a large pediatric IBD center.